Watch Ticker

PLUS THERAPEUTICS, Inc. Common Stock

Go to PLUS THERAPEUTICS, Inc. Common Stock Website

$0.72

0.06 (9.70%)

Live

Previous Close

$0.658

Day Range

$0.6891 - $0.7421

Previous Day Range

$0.62 - $0.9

Market Cap

$44.7 million USD

Day Vol.

5.3 million

Previous Day Vol.

48.0 million

Currency

USD

Primary Exchange

Nasdaq

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Plus Therapeutics, Inc. - Plus Therapeutics Secures Private Placement of Approximately $15 Million in Gross Proceeds

Plus Therapeutics, a clinical-stage pharmaceutical company, announced the pricing of a $15.0 million private placement. The funds will be used to advance the company's central nervous system cancer therapies and meet key near-term milestones.

Related tickers: PSTV.

Read Full Article

Plus Therapeutics Inc. - Plus Therapeutics to Present at the Gordon Research Conference Radionuclide Theranostics for the Management of Cancer

Plus Therapeutics to Present at the Gordon Research Conference Radionuclide Theranostics for the Management of Cancer

Related tickers: PSTV.

Read Full Article

Trending Tickers

Please sign in to view